|
Device Problem
Migration (4003)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/18/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(4).The wallflex esophageal stent has not been received for analysis.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.Stent migration is a known potential adverse effect associated with esophageal stent placement and is noted within the instructions for use (ifu) / product label.Therefore, the investigation concludes that the most probable cause of the event is a known inherent risk of the device.
|
|
Event Description
|
It was reported to boston scientific corporation on (b)(6) 2022 that a wallflex esophageal stent was implanted in the mid esophagus to treat a tracheoesophageal fistula during a procedure performed on an unknown date.On (b)(6) 2022, post stent placement, the wallflex esophageal stent migrated.It was noted that it was not a complete migration.The stent was removed from the patient and an agile esophageal stent was implanted and the procedure was completed.There were no patient complications reported as a result of this event.
|
|
Manufacturer Narrative
|
Blocks b5 has been updated with additional information received on june 10, 2022.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: medical device problem code a010402 captures the reportable event of stent migration.Impact code f23 captures the additional intervention of stent removal and replacement of the migrated stent.Block h10: the wallflex esophageal stent has not been received for analysis.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.Stent migration is a known potential adverse effect associated with esophageal stent placement and is noted within the instructions for use (ifu) / product label.Therefore, the investigation concludes that the most probable cause of the event is a known inherent risk of the device.
|
|
Event Description
|
It was reported to boston scientific corporation on may 18, 2022 that a wallflex esophageal stent was implanted in the mid esophagus to treat a tracheoesophageal fistula during a procedure performed on an unknown date.On may 18, 2022, post stent placement, the wallflex esophageal stent migrated.It was noted that it was not a complete migration.The stent was removed from the patient and an agile esophageal stent was implanted and the procedure was completed.There were no patient complications reported as a result of this event.Additional information received on june 10, 2022.The complainant reported that the stent migrated about an inch in the center of the esophagus.
|
|
Search Alerts/Recalls
|
|
|